Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.
A phase 3 trial of Hetrombopag in advanced solid tumours, run by Jiangsu HengRui Medicine Co., Ltd., active and no longer recruiting.
Overview
Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors. is a phase 3 interventional study registered as NCT05864014 by Jiangsu HengRui Medicine Co., Ltd., with 213 participants enrolled, started 2023-04-25 and due to reach its primary completion in 2025-03-03. Interventions recorded: Hetrombopag, Hetrombopag plus Placebo and Placebo.
Similar pages
not linked directly; found by shared links- TrialA TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant Tumors
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialPhase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of SHR-4375 in Subjects With Solid Tumors
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors
Shares Jiangsu Hengrui Pharmaceuticals, Metastatic cancer (cancer that has spread) and the tag pipeline.